Value of the Serum Thyroglobulin Level Alteration at the First High Dose Radioiodine Treatment in Patients with Differentiated Thyroid Carcinoma
![]() |
Nam, Hyun-Yeol
(Department of Nuclear Medicine, Pusan National University Hospital)
Kim, In-Joo (Department of Nuclear Medicine, Pusan National University Hospital) Kim, Yong-Ki (Department of Nuclear Medicine, Pusan National University Hospital) Kim, Seong-Jang (Department of Nuclear Medicine, Pusan National University Hospital) Jun, Sung-Min (Department of Nuclear Medicine, Pusan National University Hospital) Kim, Bum-Soo (Department of Nuclear Medicine, Pusan National University Hospital) |
1 | Pacini F. Ladenson PW, Schlumberger M, Driedger A, Luster M, Kloos RT, et al. Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study. J Clin Endocrinol Metab 2006;91:926-32 DOI ScienceOn |
2 | Torrens J, Burch HB. Serum thyroglobulin measurement: Utility in clinical practice. Endocrinol Metab Clin North Am 2001;30:1-34 DOI ScienceOn |
3 | Lima N, Cavaliere H, Tomimori E, Knobel M, Medeiros-Neto G. Prognostic value of serial serum thyroglobulin determinations after total thyroidectomy for differentiated thyroid cancer. J Endocrinol Invest 2002;25:110-5 DOI PUBMED ScienceOn |
4 | Cramp WA, Yatvin MB, Harms-Ringdahl M. Recent developments in the radiobiology of cellular membranes. Acta Oncol 1994;33:945-52 DOI ScienceOn |
5 | Rosario PW, Purisch S. Does a highly sensitive thyroglobulin (Tg) assay change the clinical management of low-risk patients with thyroid cancer with Tg on T4 <1 ng/ml determined by traditional assays? Clin Endocrinol (Oxf) 2008;68:338-42 DOI PUBMED ScienceOn |
6 | Sugino K, Ito K, Takami H. Management of differentiated thyroid carcinoma with radioiodine and recombinant human TSH. Endocr J 2006;53:723-8 DOI ScienceOn |
7 |
Arslan N, Ilgan S, Serdengecti M, Ozguven MA, Bayhan H, Okuyucu K, et al. Post-surgical ablation of thyroid remnants with high-dose |
8 | Dow KH, Ferrell BR, Anello C. Quality of life changes in patients with thyroid cancer after withdrawal of thyroid hormone therapy. Thyroid 1997;7:613-9 DOI ScienceOn |
9 | Luster M, Clarke SE, Dietlein M, Lassmann M, Lind P, Oven WJ, et al. Guidelines for radioiodine therapy of differentiated thyroid cancer. Eur J Nucl Med Mol Imaging 2008;35:1941-59 DOI ScienceOn |
10 | Robbins RJ, Robbins AK. Clinical review 156: recombinant human thyrotropin and thyroid cancer management. J Clin Endocrinol Metab 2003;88:1933-8 DOI ScienceOn |
11 | Bernier MO, Morel O, Rodien P, Muratet JP, Giraud P, Rohmer V, et al. Prognostic value of an increase in the serum thyroglobulin level at the time of the first ablative radioiodine treatment in patients with differentiated thyroid cancer. Eur J Nucl Med Imaging 2005;32:1418-21 DOI ScienceOn |
12 | Sweeney DC, Johnston GS. Radioiodine therapy tor thyroid cancer. Endocrinol Metab Clin North Am 1995;24:803-39 |
13 | Schlumberger M, Pacini F, Wiersinga WM, Toft A, Smit JW, Sanchez Franco F, et al. Follow-up and management of differentiated thyroid carcinoma: a European perspective in clinical practice. Eur J Endocrinol 2004;151:539-48 DOI ScienceOn |
14 | Mazzaferri EL. An overview of the management of papillary and follicular thyroid carcinoma. Thyroid 1999;9:421-7 DOI ScienceOn |
15 | Mazzaferri EL, Kloos RT. Clinical review 128: current approaches to primary therapy tor papillary and follicular thyroid cancer. J Clin Endocrinol Metab 2001;86:1447-63 DOI ScienceOn |
16 | Schroeder PR, Haugen BR, Pacini F, Reiners C, Schlumberger M, Sherman SI, et al. A comparison of short-term changes in health-related quality of life in thyroid carcinoma patients undergoing diagnostic evaluation with recombinant human thyrotropin compared with thyroid hormone withdrawal. J Clin Endocrinol Metab 2006;91:878-84 DOI ScienceOn |
17 | Tuttle RM, Brokhin M, Omry G, Martorella AJ, Larson SM, Grewal RK, et al. Recombinant-human TSH-assisted radioactive iodine remnant ablation achieves short term clinical recurrence rates similar to those of traditional thyroid hormone withdrawal. J Nucl Med 2008;49:764-70 DOI ScienceOn |
18 | Karam M, Gianoukakis A, Feustel PJ, Cheema A, Postal ES, Cooper JA. Influence of diagnostic and therapeutic doses on thyroid remnant ablation rates. Nucl Med Commun 2003;24:489-95 DOI ScienceOn |
19 | Giovanella L, Ceriani L, Ghelfo A, Keller F, Sacchi A, Maffioli M, et at. Thyroglobulin assay during thyroxine treatment in low-risk differentiated thyroid cancer management: comparison with recombinant human thyrotropin-stimulated assay and imaging procedures. Clin Chem Lab Med 2006;44:648-52 DOI ScienceOn |
20 | Sawka AM, Thephamongkhol K, Brouwers M, Thabane L, Browman G, Gerstein He. Clinical review 170: a systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer. J Clin Endocrinol Metab 2004;89:3668-76 DOI ScienceOn |
21 | Crevenna R, Zettinig G, Keilani M, Posch M, Schmidinger M, Pirich C, et al. Quality of life in patients with non-metastatic differentiated thyroid cancer under thyroxin supplementation therapy. Support Cancer Care 2003;11:597-603 DOI ScienceOn |
22 |
Toubeau M, Touzery C, Arveux P, Chaplain G, Vaillant G, Berriolo A, et al. Predictive value for disease progression of serum thyroglobulin levels measured in the postoperative period and after |
23 | Ronga G, Filesi M, Ventroni G, Vestri AR, Signore A Value of the first serum thyroglobulin level after total thyroidectomy for the diagnosis of metastases from differentiated thyroid carcinoma. Eur J Nucl Med 1999;26:1448-52 DOI ScienceOn |
24 | Botella-Carretero JI, Galan JM, Caballero C, Sancho J, Escobar-Morreale HF. Quality of life and psychometric functionality in patients with differentiated thyroid carcinoma. Endocr Relat Cancer 2003;10:601-10 DOI ScienceOn |
25 |
Menzel C, Kranert WT, Dobert N, Diehl M, Fietz T, Harnscho N, et al. rhTSH stimulation before radioiodine therapy in thyroid cancer reduces the effective half-life of |
26 |
Lee HJ, Rha SY, Jo YS, Kim SM, Ku BJ, Shong M, et al. Predictive value of the preablation serum thyroglobulin level after thyroidectomy is combined with postablation |
![]() |